期刊缩写:
Tumor Biol.
ISSN:
print: 1010-4283
on-line: 1423-0380
研究领域:
医学-肿瘤学
创刊年份:
2010年
h-index:
70
Gold OA文章占比:
0.00%
原创研究文献占比:
0.00%
SCI收录类型:
Scopus (CiteScore) || Directory of Open Access Journals (DOAJ)
期刊介绍英文:
Tumor Biology is a peer reviewed, international journal providing an open access forum for experimental and clinical cancer research. Tumor Biology covers all aspects of tumor markers, molecular biomarkers, tumor targeting, and mechanisms of tumor development and progression. Specific topics of interest include, but are not limited to: Pathway analyses, Non-coding RNAs, Circulating tumor cells, Liquid biopsies, Exosomes, Epigenetics, Cancer stem cells, Tumor immunology and immunotherapy, Tumor microenvironment, Targeted therapies, Therapy resistance Cancer genetics, Cancer risk screening. Studies in other areas of basic, clinical and translational cancer research are also considered in order to promote connections and discoveries across different disciplines. The journal publishes original articles, reviews, commentaries and guidelines on tumor marker use. All submissions are subject to rigorous peer review and are selected on the basis of whether the research is sound and deserves publication. Tumor Biology is the Official Journal of the International Society of Oncology and BioMarkers (ISOBM).
CiteScore:
CiteScoreSJRSNIPCiteScore排名
5.40.5760.594
学科
排名
百分位
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
126 / 230
45%
发文信息
历年影响因子
历年发表
2012年336
2013年863
2014年1410
2015年1682
2016年809
2017年709
2018年516
2019年884
2020年275
2021年324
2022年18
投稿信息
出版周期:
Bimonthly
出版语言:
English
出版国家(地区):
SWITZERLAND
接受率:
100%
审稿时长:
1 months
出版商:
Springer Netherlands
编辑部地址:
SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ

Tumor Biology - 最新文献

Lack of clinical utility of serum macrophage migration inhibitory factor (MIF) for monitoring therapy response and estimating prognosis in advanced lung cancer.

Pub Date : 2024-01-01 DOI: 10.3233/TUB-230006 Alexander Rupp, Sophie Bahlmann, Nicolai Trimpop, Joachim von Pawel, Stefan Holdenrieder

CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan.

Pub Date : 2024-01-01 DOI: 10.3233/TUB-220042 Thomas Muley, Mark A Schneider, Michael Meister, Michael Thomas, Claus Peter Heußel, Mark Kriegsmann, Stefan Holdenrieder, Birgit Wehnl, Vinzent Rolny, Anika Mang, Rebecca Gerber, Felix Herth

Lung cancer biomarkers: Raising the clinical value of the classical and the new ones.

Pub Date : 2024-01-01 DOI: 10.3233/TUB-240004 Stefan Holdenrieder, Huub H van Rossum, Michel van den Heuvel
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信